Research Group Translational Hepatology and Stem Cell Biology, Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30625, Hannover, Germany.
REBIRTH-Research Center for Translational Regenerative Medicine, Hannover Medical School, 30625, Hannover, Germany.
Sci Rep. 2021 Nov 12;11(1):22154. doi: 10.1038/s41598-021-01689-2.
CRISPR prime-editors are emergent tools for genome editing and offer a versatile alternative approach to HDR-based genome engineering or DNA base-editors. However, sufficient prime-editor expression levels and availability of optimized transfection protocols may affect editing efficiencies, especially in hard-to-transfect cells like hiPSC. Here, we show that piggyBac prime-editing (PB-PE) allows for sustained expression of prime-editors. We demonstrate proof-of-concept for PB-PE in a newly designed lentiviral traffic light reporter, which allows for estimation of gene correction and defective editing resulting in indels, based on expression of two different fluorophores. PB-PE can prime-edit more than 50% of hiPSC cells after antibiotic selection. We also show that improper design of pegRNA cannot simply be overcome by extended expression, but PB-PE allows for estimation of effectiveness of selected pegRNAs after few days of cultivation time. Finally, we implemented PB-PE for efficient editing of an amyotrophic lateral sclerosis-associated mutation in the SOD1-gene of patient-derived hiPSC. Progress of genome editing can be monitored by Sanger-sequencing, whereas PB-PE vectors can be removed after editing and excised cells can be enriched by fialuridine selection. Together, we present an efficient prime-editing toolbox, which can be robustly used in a variety of cell lines even when non-optimized transfection-protocols are applied.
CRISPR 先导编辑是基因组编辑的新兴工具,为基于 HDR 的基因组工程或 DNA 碱基编辑器提供了一种多功能的替代方法。然而,足够的先导编辑表达水平和优化的转染方案的可用性可能会影响编辑效率,特别是在难以转染的细胞如 hiPSC 中。在这里,我们表明 piggyBac 先导编辑(PB-PE)允许持续表达先导编辑。我们在新设计的慢病毒交通灯报告基因中证明了 PB-PE 的概念验证,该报告基因可以基于两种不同荧光蛋白的表达来估计基因校正和导致插入缺失的无效编辑。在抗生素选择后,PB-PE 可以编辑超过 50%的 hiPSC 细胞。我们还表明,pegRNA 的设计不当不能简单地通过延长表达来克服,但 PB-PE 允许在几天的培养时间后估计所选 pegRNA 的有效性。最后,我们在患者来源的 hiPSC 中的 SOD1 基因中实施了 PB-PE 对肌萎缩侧索硬化相关突变的有效编辑。基因组编辑的进展可以通过 Sanger 测序进行监测,而 PB-PE 载体可以在编辑后去除,并且可以通过氟尿嘧啶选择富集编辑细胞。总之,我们提出了一种高效的先导编辑工具包,即使在应用非优化的转染方案时,也可以在各种细胞系中可靠地使用。